Exchange Traded Concepts, LLC Cerus Corp Transaction History

Exchange Traded Concepts, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	BUY	$1.79 - $2.9 $141,916 - $229,920	79,283 Added 23.78%	412,723 $1.02 Million
Q1 2023 Apr 12, 2023	BUY	$2.65 - $3.81 $238,473 - $342,861	89,990 Added 36.96%	333,440 $990,000
Q4 2022 Jan 17, 2023	SELL	$3.38 - $4.22 $15,767 - $19,686	-4,665 Reduced 1.88%	243,450 $889,000
Q3 2022 Oct 07, 2022	BUY	$3.43 - $5.83 $152,974 - $260,012	44,599 Added 21.91%	248,115 $893,000
Q2 2022 Jul 20, 2022	SELL	$4.41 - $5.69 $138,685 - $178,939	-31,448 Reduced 13.38%	203,516 $1.08 Million
Q1 2022 Apr 26, 2022	SELL	$4.81 - $6.99 $82,111 - $119,326	-17,071 Reduced 6.77%	234,964 $1.29 Million
Q4 2021 Jan 13, 2022	SELL	$5.97 - $7.93 $427,386 - $567,700	-71,589 Reduced 22.12%	252,035 $1.72 Million
Q3 2021 Oct 18, 2021	SELL	$4.79 - $6.68 $141,118 - $196,799	-29,461 Reduced 8.34%	323,624 $1.97 Million
Q2 2021 Jul 30, 2021	BUY	$5.35 - $6.35 $398,323 - $472,776	74,453 Added 26.72%	353,085 $2.09 Million
Q1 2021 Apr 20, 2021	BUY	$5.68 - $7.87 $779,029 - $1.08 Million	137,153 Added 96.94%	278,632 $1.68 Million
Q4 2020 Jan 19, 2021	BUY	$5.25 - $8.56 $386,064 - $629,468	73,536 Added 108.23%	141,479 $979,000
Q3 2020 Oct 30, 2020	BUY	$5.78 - $7.47 $176,983 - $228,731	30,620 Added 82.04%	67,943 $425,000
Q2 2020 Jul 15, 2020	BUY	$4.5 - $7.02 $90,886 - $141,782	20,197 Added 117.93%	37,323 $246,000
Q1 2020 Apr 14, 2020	BUY	$2.87 - $5.49 $10,062 - $19,247	3,506 Added 25.74%	17,126 $80,000
Q4 2019 Jan 22, 2020	BUY	$3.84 - $4.86 $52,300 - $66,193	13,620 New	13,620 $57,000

157

148M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $321M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.